MACROGENICS INC (MGNX)

↓ Download CSV

CIK 0001125345 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, MACROGENICS INC reported revenue of $149.50M, down 0.3% from the prior year. The company ran a net loss, with a net margin of -49.9%. It held $256.85M in total assets against $201.25M in total liabilities.

Key ratios (FY2025)

-48.7%
Operating margin
-49.9%
Net margin
-134.2%
Return on equity
-0.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$149.50M$149.96M$58.75M$151.94M$77.45M$104.88M$64.19M$60.12M$157.74M$91.88M
Cost of Revenue$0$847.0K$619.0K$3.35M$2.65M$0$0
Operating Income-$72.84M-$110.58M-$168.24M-$121.42M-$202.79M-$131.06M-$177.19M-$171.21M-$22.14M-$60.04M
Net Income-$74.62M-$66.97M-$9.06M-$119.76M-$202.12M-$129.74M-$151.81M-$171.45M-$19.63M-$58.53M
EPS (Diluted)$-1.18$-1.07$-0.15$-1.95$-3.37$-2.47
Total Assets$256.85M$261.65M$298.42M$280.47M$335.25M$378.74M$312.50M$332.13M$373.88M$311.26M
Total Liabilities$201.25M$145.60M$145.81M$138.46M$95.63M$82.86M$81.87M$89.25M$74.64M$42.51M
Shareholders' Equity$55.59M$116.06M$152.61M$142.01M$239.62M$295.88M$230.63M$242.88M$299.24M$268.75M
Cash & Equivalents$57.22M$182.84M$100.96M$108.88M$123.47M$181.13M$126.47M$220.13M$211.73M$84.10M
Operating Cash Flow-$81.04M-$68.37M-$78.20M-$86.96M-$143.83M-$111.90M-$134.27M-$153.23M$14.40M
Capital Expenditures$1.91M$3.71M$1.76M$3.62M$6.20M$5.91M$4.29M$24.95M$29.40M$11.38M
Shares Outstanding63.32M62.82M62.07M61.70M61.31M56.24M48.96M42.35M36.86M34.87M